About Ki-Hong Ahn
Ki-Hong Ahn is a director at Immunomic Therapeutics.
Ki-Hong Ahn first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ki-Hong Ahn in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ki-Hong Ahn works with at each company, as listed on that company's latest Form D.
Immunomic Therapeutics, Inc. · Form D, Jun 2, 2025
YJ
Yang Gon Jin
Director
SP
Steve Park
Director
RA
Robert Ahlgren
Director
DK
Dong-Gun Kim
Executive officer and director
JW
James Wishart
Director
MC
Matthew Chang
Director